Cognition Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cognition Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cognition Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cognition Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $53 | 75 | 0.71 |
| 2024-09-30 | $37 | 78 | 0.47 |
| 2024-03-31 | $127 | 70 | 1.81 |
| 2023-12-31 | $64 | 35 | 1.86 |
| 2023-09-30 | $36 | 25 | 1.44 |
| 2023-06-30 | $92 | 50 | 1.84 |